COFCO Biotechnology Co., Ltd.

COFCO Biotechnology Co., Ltd., established in 1998 and headquartered in Bengbu, China, specializes in the comprehensive processing and manufacturing of agricultural products across China. Its extensive product portfolio includes a variety of corn-based starches, such as edible, special, waxy, and modified waxy types. The company also supplies an array of feed ingredients, including corn gluten meal, sprayed corn husk, corn germ meal, and distillers' dried grains with solubles (DDGS), as well as raw materials for fertilizers and glutamic acid residue. COFCO Biotechnology manufactures diverse sweeteners like fructose and functional sugar alcohols, alongside fuel and edible alcohols, and even liquors. Biochemicals such as monosodium glutamate, citric acid, potassium citrate, polylactic acid, phytosterols, and natural vitamin E are also key outputs. Beyond these, its offerings extend to various edible oils (including corn crude, corn germ, rapeseed, peanut, and soybean oil), a range of syrups (fructose, maltose, glucose, oligomeric isomalt, and beer syrups), and essential packaging solutions (plastic woven bags, barrels, container bags, and diverse paper products). Additional specialized products encompass corn fiber feed, bacterial protein, microorganisms, compound antioxidants, and nutritious health foods. COFCO Biotechnology also provides essential support services like warehousing, logistics, and information consulting. Furthermore, the company's operational scope is remarkably broad, encompassing research and development in biological engineering, the production and sale of amino acids and both compound and organic fertilizers, and the trade of chemical products and grains. Its activities extend to the wholesale and retail of edible agricultural products, the export of its own products and associated technologies, and the import of necessary raw materials, equipment, and technologies. The firm is also involved in steam production and sales, coal wholesale, food and food additive manufacturing and sales, house leasing, food procurement, power generation, and the distribution of pre-packaged, bulk, and dairy food items. The company underwent a rebranding in September 2019, transitioning from its former name, COFCO Biochemical (Anhui) Co., Ltd., to its current designation, COFCO Biotechnology Co., Ltd.

COFCO Biotechnology Co., Ltd. trades as 000930.SZ on SHZ. The company is classified in Basic Materials / Chemicals - Specialty and reports in CNY.

The current profile places the business in Chemicals - Specialty. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Detailed operating-segment data is not available for this symbol yet.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

COFCO Biotechnology Co., Ltd. can be compared against peers such as CSG Holding Co., Ltd., Yunnan Energy Investment Co., Ltd., Lianhe Chemical Technology Co., Ltd., Tibet GaoZheng Explosive Co., Ltd., Shandong Dawn Polymer Co.,Ltd., Huabao Flavours & Fragrances Co., Ltd..

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of $9.00B, beta of 0.24, and return on equity of N/A.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

000930.SZ currently shows total debt of N/A and beta of 0.24. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

No recent SEC-style filings are available for this symbol yet.

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://www.cofcotech.com

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.